(NASDAQ: DERM) Journey Medical's forecast annual revenue growth rate of -0.74% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Journey Medical's revenue in 2024 is $79,890,000.On average, 1 Wall Street analysts forecast DERM's revenue for 2024 to be $1,074,415,464, with the lowest DERM revenue forecast at $1,074,415,464, and the highest DERM revenue forecast at $1,074,415,464. On average, 1 Wall Street analysts forecast DERM's revenue for 2025 to be $1,185,095,989, with the lowest DERM revenue forecast at $1,185,095,989, and the highest DERM revenue forecast at $1,185,095,989.
In 2026, DERM is forecast to generate $1,476,233,892 in revenue, with the lowest revenue forecast at $1,476,233,892 and the highest revenue forecast at $1,476,233,892.